Alira Health

Market Access, Pricing and Reimbursement

Realizing Opportunities in Pharma, Medtech and Vaccines

pricing and reimbursement strategy pharma
We’ll Work Closely With You to Uncover Opportunities, Accelerate Innovation, and Deliver Tomorrow’s Standard of Care

Our market access team helps clients demonstrate value, optimize patient access, and realize the commercial opportunity for their health care and life sciences innovations.

Whether you need to understand which asset best aligns with your long-term strategy, which new market or therapeutic area to explore, or how to expand into another sector, we are ready to help you lead the way.

How We Help Clients

Why Choose Us for Market Access Support?

The EU HTA Regulation (EU 2021/2282) is already transforming access across Europe.
Alira Health brings first-wave JCA experience and delivers rapid, end-to-end HTA readiness. We work with your teams to implement JCA-ready frameworks across governance, processes, and evidence generation. 

Act now—engage Alira Health to stay ahead from early development through JCA and national access.
Jean-François Ricci

Our strong client partnerships allow us to deliver in-depth, customized strategies and access solutions—all designed to maximize product value across its full lifecycle."

Market Access Activities

Turn complex planning into clear decisions with the Digital Pathology Net Present Value Model calculator that helps you assess value, optimize strategy, and communicate impact.

Contact Us to Learn More About How We Can Support Your Needs

 

Welcome to Alira Health. This site is best viewed in Chrome, Microsoft Edge, or Firefox.